Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Jansen

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Clinical Immunology and Immunopathology|July 1, 1994
Re: Pathways of complement activation in sepsisC E Hack, G J Wolbink, P M Jansen, et al.
Annals of the Rheumatic Diseases|February 23, 2008
Topical opioids for painful ulcers in systemic sclerosisI L A van Ingen, M M P M Jansen, P Barrera
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 20, 2009
Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapyE P M Jansen, H Boot, R Dubbelman, et al.
The British Journal of Dermatology|May 7, 2009
Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disordersM F Benner, P M Jansen, C J L M Meijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literatureM W Bekkenk, P M Jansen, C J L M Meijer, et al.
British Journal of Cancer|September 13, 2007
Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapyE P M Jansen, H Boot, R Dubbelman, et al.
The British Journal of Dermatology|September 5, 2001
Lymphomatoid papulosis with a natural killer-cell phenotypeM W Bekkenk, P M Kluin, P M Jansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2005
Optimal locoregional treatment in gastric cancerEdwin P M Jansen, Henk Boot, Marcel Verheij, et al.
International Journal of Pharmaceutics|May 28, 2013
Controlled release of morphine from a poloxamer 407 gelMark M P M Jansen, Jacques M Verzijl, David M Burger, et al.
Personality and Mental Health|December 18, 2013
The Standardized Assessment of Personality-Abbreviated Scale as a screening instrument for personality disorders in substance-dependent criminal offendersBrigitte P M Jansen, Katinka F M Damen, Tonko O Hoffman, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Clinical Immunology and Immunopathology|July 1, 1994
Re: Pathways of complement activation in sepsisC E Hack, G J Wolbink, P M Jansen, et al.
Annals of the Rheumatic Diseases|February 23, 2008
Topical opioids for painful ulcers in systemic sclerosisI L A van Ingen, M M P M Jansen, P Barrera
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 20, 2009
Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapyE P M Jansen, H Boot, R Dubbelman, et al.
The British Journal of Dermatology|May 7, 2009
Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disordersM F Benner, P M Jansen, C J L M Meijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literatureM W Bekkenk, P M Jansen, C J L M Meijer, et al.
British Journal of Cancer|September 13, 2007
Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapyE P M Jansen, H Boot, R Dubbelman, et al.
The British Journal of Dermatology|September 5, 2001
Lymphomatoid papulosis with a natural killer-cell phenotypeM W Bekkenk, P M Kluin, P M Jansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2005
Optimal locoregional treatment in gastric cancerEdwin P M Jansen, Henk Boot, Marcel Verheij, et al.
International Journal of Pharmaceutics|May 28, 2013
Controlled release of morphine from a poloxamer 407 gelMark M P M Jansen, Jacques M Verzijl, David M Burger, et al.
Personality and Mental Health|December 18, 2013
The Standardized Assessment of Personality-Abbreviated Scale as a screening instrument for personality disorders in substance-dependent criminal offendersBrigitte P M Jansen, Katinka F M Damen, Tonko O Hoffman, et al.
Pageof 12